Clinical Trial Details
| Trial ID: | L1647 |
| Source ID: | NCT00442793 |
| Associated Drug: | Epoetin Beta |
| Title: | A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease. |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Anemia |
| Interventions: | DRUG: Epoetin beta|DRUG: methoxy polyethylene glycol-epoetin beta [Mircera] |
| Outcome Measures: | Primary: Hb response rate, Weeks 0-24|Change in Hb concentration between baseline and evaluation period, Months 4-6 | Secondary: Hb over time, Throughout study|Time to Hb response, Throughout study|RBC transfusions, Weeks 0-24|AEs, laboratory parameters, vital signs, Throughout study|Serum concentration of Mircera, Throughout study |
| Sponsor/Collaborators: | Sponsor: Hoffmann-La Roche |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE3 |
| Enrollment: | 265 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2007-05 |
| Completion Date: | 2010-05 |
| Results First Posted: | |
| Last Update Posted: | 2016-11-02 |
| Locations: | Beijing, 100050, China|Beijing, 10029, China|Beijing, 100853, China|Chengdu, 610072, China|Guangzhou, 510515, China|Guangzhou, China|Hangzhou, 310003, China|Nanjing, 210009, China|Shanghai, 200001, China|Shanghai, 200003, China|Shanghai, 200025, China|Shanghai, 200032, China|Shanghai, 200040, China|Hong Kong, Hong Kong |
| URL: | https://clinicaltrials.gov/show/NCT00442793 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|